Ichor Medical Systems Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Ichor Medical Systems is a privately held biotechnology company based in San Diego, California. It develops the TriGrid delivery system, an integrated, automated platform intended to administer DNA therapies in humans via electroporation. The company aims to support the delivery of DNA drugs and vaccines across a range of disease areas through collaboration with partners. Target applications include cancer, hepatitis B, HIV, Ebola, and other biodefense contexts, where the TriGrid platform is used to facilitate DNA-based treatment administration. In 2021, Ichor entered into a licensing agreement with Immunomic Therapeutics to co-develop ITI-1001 for newly diagnosed glioblastoma. The organization operates with a small team and pursues partnerships to advance clinical testing of DNA therapeutics.